ABOUT US
WHAT WE DO
BUSINESS RELATIONSHIPS
CAREERS
CONTACT US
Products
OVERVIEW
ADVANCED WOUND CARE
VASCULAR ACCESS
PERIOPERATIVE CARE
UROLOGY
Technology Platforms
OVERVIEW
COVAGUARD™ PLATFORM
BIOMATRIX PLATFORM
ANTIMICROBIAL SILICONE PLATFORM
MEDICAL COATING PLATFORM
COVALON OEM
INVESTORS
Home
News and Events
Stock Details
SEDAR® Filings
Corporate Governance
Resources
Contact Us
BUY NOW
ABOUT US
WHAT WE DO
BUSINESS RELATIONSHIPS
CAREERS
CONTACT US
Products
OVERVIEW
ADVANCED WOUND CARE
VASCULAR ACCESS
PERIOPERATIVE CARE
UROLOGY
Technology Platforms
OVERVIEW
COVAGUARD™ PLATFORM
BIOMATRIX PLATFORM
ANTIMICROBIAL SILICONE PLATFORM
MEDICAL COATING PLATFORM
COVALON OEM
INVESTORS
Home
News and Events
Stock Details
SEDAR® Filings
Corporate Governance
Resources
Contact Us
BUY NOW
Email Alerts
Investor Relations
Home
News and Events
Press Releases
Events
Stock Details
Stock Quote and Chart
Historical Stock Price
Investment Calculator
SEDAR® Filings
Corporate Governance
Management
Board of Directors
Documents and Committees
Resources
Email Alerts
Investor FAQs
Online Investor Kit
Contact Us
* Required Fields
(Click here to unsubscribe)
All Alerts
Customize Alerts
Events and Webcasts
Daily Closing Stock Price
Stock Price: End of Week Summary
News Releases
All SEDAR® Filings
News Releases
Code of Conduct
Material Contracts
Other
Financial Statements
Management's Discussion & Analysis
Material Change Report
Annual Information Form
Notice of the Meeting and Record Date
Proxy Circular
Technical Report - NI 43-101
Early Warning Report
Marketing Materials
Prospectus
Documents Affecting Rights of Securityholders
Statement of Executive Compensation
Report of Exempt Distribution
NI 44-101 Notice
Annual Report
Annual Statement of Payments
Disclosure For Oil and Gas Activities NI 51-101
Notice Form 45-102F1
Issuer Bid Circular
Offering Material
Listing Application
Fund Facts / Fund Summary
Management Report of Fund Performance
Offering Memorandum
Offering Document
ETF Facts / Summary Disclosure Documents
Proxy Solicitation by Third Parties
Reports under NI 81-107
Exemptive Relief Applications
First Name
Last Name
* Email
Company
Phone
